<DOC>
	<DOCNO>NCT00353483</DOCNO>
	<brief_summary>The main purpose study compare genetic marker present tumor cell chemotherapy .</brief_summary>
	<brief_title>Effect Chemotherapy Administered Before Surgery Breast Cancers , Bone Marrow Cancer Cells , Circulating Cancer Cells</brief_title>
	<detailed_description>In study , investigator propose persistent disseminated tumor cell ( DTC ) present chemotherapy represent unique subpopulation DTC , predictor poor response chemotherapy , correlate poor clinical outcome . The investigator hypothesize chemotherapy-resistant DTC identify expression unique constellation tumor marker protein may similar express breast cancer stem cell . In research , investigator ' specific aim : 1 ) characterize tumor marker express DTC present chemotherapy , 2 ) compare expression marker DTC detect prior chemotherapy , 3 ) correlate expression define tumor marker DTC clinical outcome breast cancer patient identify marker predictive disease recurrence , 4 ) utilize biomarkers identify Specific Aims 1 2 isolate purify DTC molecular analysis .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bone Marrow Neoplasms</mesh_term>
	<criteria>Recently diagnose clinical stage II , III , IV breast cancer Planning undergo neoadjuvant chemotherapy ; patient already complete neoadjuvant chemotherapy also eligible Must &gt; = 18 year age If female , must pregnant Must willing able sign inform consent document</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Breast Cancer</keyword>
	<keyword>Neoadjuvant</keyword>
</DOC>